MK-4827 Racemate
CAS No. 1038915-75-1
MK-4827 Racemate( Niraparib Racemate | 2-(4-piperidin-3-ylphenyl)indazole-7-carboxamide )
Catalog No. M27657 CAS No. 1038915-75-1
MK-4827 Racemate is a selective PARP1 and PARP2 inhibitor with IC50s of 3.8 nM and 2.1 nM, respectively, over 330-fold selectivity for PARP3, V-PARP and Tank1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 115 | In Stock |
|
| 2MG | 60 | In Stock |
|
| 5MG | 85 | In Stock |
|
| 10MG | 148 | In Stock |
|
| 25MG | 282 | In Stock |
|
| 50MG | 482 | In Stock |
|
| 100MG | 649 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMK-4827 Racemate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMK-4827 Racemate is a selective PARP1 and PARP2 inhibitor with IC50s of 3.8 nM and 2.1 nM, respectively, over 330-fold selectivity for PARP3, V-PARP and Tank1.
-
DescriptionMK-4827 Racemate is a selective PARP1 and PARP2 inhibitor with IC50s of 3.8 nM and 2.1 nM, respectively, over 330-fold selectivity for PARP3, V-PARP and Tank1.
-
In Vitro——
-
In Vivo——
-
SynonymsNiraparib Racemate | 2-(4-piperidin-3-ylphenyl)indazole-7-carboxamide
-
PathwayCell Cycle/DNA Damage
-
TargetPARP
-
RecptorDNA/RNA Synthesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1038915-75-1
-
Formula Weight320.396
-
Molecular FormulaC19H20N4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNC(=O)c1cccc2cn(nc12)-c1ccc(cc1)C1CCCNC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.James D Thorpe, et al. Mechanochemical Synthesis of Short DNA Fragments. Chemistry. 2020 Jul 22;26(41):8857-8861.
molnova catalog
related products
-
WAY-620473
WAY-620473 is a potent PARP-1 inhibitor with antitumor activity and alters eukaryotic lifespan.
-
ARTD10/PARP10-IN-1
ARTD10/PARP10-IN-1 is a potent PARP inhibitor of the mono-ADP ribosyltransferases ARTD7/PARP15, ARTD8/PARP14, ARTD10/PARP10 and poly ADP-ribose polymerase-1 (ARTD1/PARP1), with potential anticancer and antitumour activity for the study of prostate and breast cancers.
-
DR 2313
DR 2313 is a competitive inhibitor of poly(ADP-ribose) polymerase (IC50: 0.20 and 0.24 μM for PARP-1 and PARP-2 respectively).
Cart
sales@molnova.com